Sanofi and Regeneron have celebrated a pair of positive clinical trials in inflammatory skin disorders with blockbuster immunology therapy Dupixent that could both lead to new indications for the ...

After a long road that included a three-month delay as the agency pushed for additional data, the US FDA has approved Sanofi and Regeneron's Dupixent (dupilumab) for COPD - as has China's National ...

The Punjab government has launched a project to provide assistive devices to differently-abled persons in the province. The submission of applications under the project has begun. Punjab Chief ...

Expertise Smart home devices, outdoors gadgets, smartphones, wearables, kid's tech, and some dabbling in 3D printing Credentials Covered the mobile and smart home tech space for the past five ...

Right now, creating a smart home is easier than ever, with thousands of devices selling the convenience of automation, voice control, and routine. These smart home devices have become more ...

NovoPen ®, the first insulin pen injector, was introduced in 1985. This article reviews the published evidence over two decades of use of the NovoPen ® family of injection devices in diabetes ...

However, these features require a lot of on-device computing power, so it's worth checking if your device is compatible. Here's a complete list of every device that will work with Apple Intelligence.

Cordless vacuums are often lighter and easier to use than standard vacuums. We tested a number of the most popular cordless vacuums today to find the ones that are worth your money. Live TV ...

This is how biologic treatments can help. Dupixent (dupilumab) was the first biologic treatment approved for atopic dermatitis. It became available in 2017. It is currently approved for adults, ...

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world ...